“Some days I wake up and can’t believe how much we’ve occur,” claimed Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Research, a multimillion greenback investigate and advocacy empire that employs one hundred thirty neuroscientists, pharmacologists and regulatory experts Doing the job to lay the groundwor